Especially, CAFs have been shown to foster CCA proliferation and drug resistance by releasing signaling molecules and ECM proteins, as well as by recruiting myeloid-derived suppressor cells via IL-6 signaling [144,145]. This evidence concerns the gene IL6 and cholangiocarcinoma.